remdesivir
Showing 51 - 60 of 60
COVID-19 Trial in Korea, Republic of, United States (biological, other, drug)
Completed
- COVID-19
- Lenzilumab
- +2 more
-
Birmingham, Alabama
- +55 more
Jul 21, 2022
COVID-19 Trial in United States (Remdesivir, Pulmozyme, IC14)
Recruiting
- COVID-19
- Remdesivir
- +6 more
-
Birmingham, Alabama
- +18 more
Jul 19, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Completed
- COVID-19
- Remdesivir
- Standard of Care
-
Anaheim, California
- +183 more
Jan 21, 2021
COVID-19 Trial in Worldwide (Remdesivir, Standard of Care)
Completed
- COVID-19
- Remdesivir
- Standard of Care
-
Anaheim, California
- +182 more
Dec 15, 2020
SARS-CoV2 Infection Trial in Worldwide (Remdesivir)
Approved for marketing
- SARS-CoV2 Infection
- Remdesivir
-
Birmingham, Alabama
- +271 more
Nov 10, 2020
COVID-19 Infection Trial in Worldwide (Plitidepsin, Dexamethasone, Remdesivir)
Recruiting
- COVID-19 Infection
- Plitidepsin
- +3 more
-
La Plata, Buenos Aires, Argentina
- +103 more
Aug 3, 2022